BRANDL TALOS Attorneys at law

Venture Capital & Start Ups | Corporate Law & Transactions | BioTech & Lifescience

Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

Working Highlights:

Advising the shareholders of Allcyte on the sale to Exscientia Advising the seller consortium, including Farallon, Global Health Investment Fund, Wellington Partners and Ventech on the sale of Themis to Merck Sharp Dohme Advising numerous start-ups and other companies in the life sciences sector on university spin-offs and technology transactions Advising Sportradar on its initial public offering on NASDAQ Advising AC Immune on the acquisition of a vaccine candidate against Parkinson's disease (Affiris)

University of Vienna, Faculty of Law (Mag. iur. 2015) Harvard Law School, Master of Laws (LL.M. 2019)